HOME

  EVENT INFORMATION

    Individual Registration
    Team Registration
    Packet Pickup
    Maps and Parking
    Pre-Race Expo
    Survivor & Memorial Activities
    FAQ
    Race Recap

  WAYS TO PARTICIPATE

    Donate/Friends for the Cure®
    Teams
    Sponsorship
    Volunteers
    Children's Area
    Publicize the Race
    Shop for the Cure®
    Advocacy
    Race Co-Chair Area

  CALENDAR OF EVENTS

  MISSION & EDUCATION

    Overview
    Screening & Detection
    Awareness & Education
    Research
    Clinical Trials
    Support Groups
    Diversity

  RACE FOR THE CURE® GRANTS

    Grants
    Grant Process
    Grants Information

  PEOPLE & PLACES OF THE RACE

    About Susan G. Komen
    About Barbara Ann Karmanos
    Honorary Chairs & Committee
    Share Your Story

  PHOTO ALBUM

    2005 Event Album
    2004 Event Album
    2003 Event Album

  MEDIA

2010 Honorary Chairs

The Honorable Debbie Stabenow
The Honorable Carolyn Cheeks Kilpatrick
The Honorable Jennifer M. Granholm and First Gentleman Mr. Daniel G. Mulhern
The Honorable and Mrs. Dave Bing, Mayor - Detroit

National Presenting Sponsor: Yoplait

"We've always thought of Yoplait® as an important piece of a happier, healthier life. For 18 years, we've played a part in women's health and well-being, promoting heart health, osteoporosis prevention and general fitness. But because breast cancer is a threat to the health and happiness of all women, our contribution - and your help - feel especially critical.

To date, Yoplait, its parent company General Mills and its Foundation have donated more than $18 million to the breast cancer cause over the past 9 years."

Local Presenting Sponsor:  Barbara Ann Karmanos Cancer Institute

Welcome to the 19th Annual Susan G. Komen Detroit Race for the Cure®, locally presented by the Barbara Ann Karmanos Cancer Institute

A breast cancer diagnosis is given around the globe every 29 seconds, in the U.S. every three minutes. This year, more than 40,000 lives will be lost to breast cancer in the U.S. alone, and 1,300 of those lives will be from Michigan.

We are continuing our advancements in research, which will one day turn breast cancer from a destructive disease to a treatable condition. Hundreds of breast cancer survivors are walking and running here with us today. They are here because of the advances in prevention, early detection, advanced diagnosis and treatment. Many advances have been discovered here at the Karmanos Cancer Institute, such as our work in isolating and preserving the world's most prominent breast cancer cell line for research.

After more than 10 years of research and development, Karmanos recently announced its launch of a new company to build and market a breast cancer screening device invented at Karmanos. What differentiates this new system from mammography, the current gold standard for breast cancer screening, is that this unique technology helps to accurately detect many early stages of breast cancer even in women with dense breast tissue, often not picked up by mammography. It also doesn't involve compression or use x-rays. The process to secure approval from the U.S. Food and Drug Administration is underway.

The Karmanos Cancer Institute and Susan G. Komen for the Cure have a remarkable partnership and have made a lot of progress over the years. Both organizations are grateful to all supporters who share our commitment to breast cancer.

The Komen Detroit Race is the largest in Michigan and among the largest nationwide. Seventy-five percent of the Race proceeds stays in metro Detroit to support breast cancer screening, education and special treatment programs. Twenty-five percent goes to Komen's national breast cancer research grant program. Last year's Race returned $1.5 million to local breast cancer screening, treatment and education programs. Going into our 19th year, Detroit's Race has raised more than $17.5 million in the fight to end breast cancer forever.

Thank you for taking an active role and participating in our 2010 Komen Detroit Race for the Cure®. Your involvement in this great cause will help bring about a future free of cancer.

Sincerely,

Gerold Bepler, M.D., Ph.D.
President and Chief Executive Officer
Karmanos Cancer Institute

Rev. 3-10-2010


Charity Navigator, a leading independent charity evaluator, has awarded Susan G. Komen for the Cure a four-out-of-four-star rating.